Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein.
The human immunodeficiency virus type 1 (HIV-1) Gag polyprotein directs the formation of virions from productively infected cells. Many gag mutations disrupt virion assembly, but little is known about the biochemical effects of many of these mutations. Protein-protein interactions among Gag monomers are believed to be necessary for virion assembly, and data suggest that RNA may modify protein-protein interactions or even serve as a bridge linking Gag polyprotein monomers. To evaluate the primary sequence requirements for HIV-1 Gag homomeric interactions, a panel of HIV-1 Gag deletion mutants was expressed in bacteria and evaluated for the ability to associate with full-length Gag in vitro. The nucleocapsid protein, the major RNA-binding domain of Gag, exhibited activity comparable to that of the complete polyprotein. In the absence of the nucleocapsid protein, relatively weak activity was observed that was dependent upon both the capsid-dimer interface and basic residues within the matrix domain. The relevance of the in vitro findings was confirmed with an assay in which nonmyristylated mutant Gags were assessed for the ability to be incorporated into virions produced by wild-type Gag expressed in trans. Evidence of the importance of RNA for Gag-Gag interaction was provided by the demonstration that RNase impairs the Gag-Gag interaction and that HIV-1 Gag interacts efficiently with Gags encoded by distantly related retroviruses and with structurally unrelated RNA-binding proteins. These results are consistent with models in which Gag multimerization involves indirect contacts via an RNA bridge as well as direct protein-protein interactions.
Burniston
M T
MT
Departments of Microbiology, Columbia University, College of Physicians and Surgeons, New York, New York 10032, USA.
Cimarelli
A
A
Colgan
J
J
Curtis
S P
SP
Luban
J
J
D000818:Animals; D002460:Cell Line; D019281:Dimerization; D015683:Gene Products, gag / Q000737:chemistry / Q000502:physiology*; D015497:HIV-1 / Q000502:physiology*; D006801:Humans; D051379:Mice; D019251:Nucleocapsid / Q000737:chemistry; D011485:Protein Binding; D012367:RNA, Viral / Q000737:chemistry / Q000502:physiology*; D014763:Viral Matrix Proteins / Q000737:chemistry / Q000502:physiology*; D014771:Virion / Q000737:chemistry / Q000502:physiology; D014779:Virus Replication
D015683:Gene Products, gag; D012367:RNA, Viral; D014763:Viral Matrix Proteins